Andina Capital Management LLC bought a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,676 shares of the health services provider's stock, valued at approximately $387,000.
Several other institutional investors have also recently made changes to their positions in MMS. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Maximus by 40.0% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock worth $117,921,000 after purchasing an additional 494,372 shares during the last quarter. SG Capital Management LLC purchased a new position in shares of Maximus during the fourth quarter worth $30,285,000. Reinhart Partners LLC. raised its holdings in shares of Maximus by 65.4% during the first quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock worth $62,156,000 after purchasing an additional 360,365 shares during the last quarter. Boston Partners purchased a new position in shares of Maximus during the first quarter worth $20,983,000. Finally, Squarepoint Ops LLC purchased a new position in shares of Maximus during the fourth quarter worth $22,661,000. Hedge funds and other institutional investors own 97.21% of the company's stock.
Analyst Ratings Changes
Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $90.00.
Read Our Latest Research Report on Maximus
Insiders Place Their Bets
In related news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the transaction, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.60% of the company's stock.
Maximus Stock Performance
MMS stock traded up $1.5160 during midday trading on Friday, hitting $86.9260. 517,681 shares of the stock traded hands, compared to its average volume of 653,839. The firm has a market cap of $4.90 billion, a P/E ratio of 16.01 and a beta of 0.60. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The stock's fifty day simple moving average is $74.51 and its 200-day simple moving average is $71.07. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company's revenue was up 2.5% compared to the same quarter last year. During the same period last year, the firm posted $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's dividend payout ratio (DPR) is currently 22.10%.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.